ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 617965 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 617965; 2) Community: the network communities that were significantly associated with the response to NSC 617965; 3) Molecule: the relationships between components within communities and NSC 617965; 4) MDR: the compounds that were significantly associated with the NSC 617965.

NSC Compound Enrichment Correlation
NSC 122621 Null 0.0284045326811616 0.44993647
NSC 166237 Ethanol, 2,2'-[[3-methyl-4-[[[4-(2-methyl-4-thiazolyl)phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester), monohydrochloride (9CI) 0.0284045326811616 0.41671584
NSC 174218 Phenol, 2,2'-[1,2-ethanediylbis(nitrilomethylidyne)]bis-, compd. with dichlorodipropylstannane (1:1) 0.0284045326811616 0.06940305
NSC 275656 m-Dioxane-5-methanol, 2,2-dimethyl-5-(4,6-diaziridinyl-2-S-triazinylamino)- 0.0284045326811616 0.51998805
NSC 345647 CHAETOCHROMIN 0.0284045326811616 0.35740827
NSC 405158 2,5-Cyclohexadiene-.delta.1,.alpha.-acetonitrile, .alpha.-(p-chlorophenyl)-4-oxo-, oxime 0.0284045326811616 0.017887134
NSC 49689 Null 0.0284045326811616 0.039335832
NSC 606985 Camptothecin Derivative 0.0284045326811616 0.3588907
NSC 613327 Gemcitabine Y 0.0284045326811616 0.43473483
NSC 615804 ANTINEOPLASTIC-615804 0.0284045326811616 0.50669428
Total:114  Current:65    [First] [Prev] [Next] [Last]